The primary endpoint of LEADERS FREE III was presented at PCR e-course 2020
June 27,2020 | News | BioFreedom™ Ultra
The study evaluates the safety and efficacy of the novel thin-strut (84µm) CoCr polymer-free DCS BioFreedom™ Ultra in HBR patients. Details are available in Professor Eberli’s presentation.
NEWEST INNOVATION COMING SOON...
BIOFREEDOM™ ULTRA, A COBALT CHROMIUM POLYMER AND CARRIER-FREE DRUG COATED CORONARY STENT SYSTEM (DCS)
June 12, 2020 | News | BioFreedom™ Ultra
Pending CE marking of this new product in Biosensors interventional cardiology portfolio, the results of the LEADERS FREE III study will be presented at the PCR eCOURSE 2020
BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN NEW PIVOTAL DRUG COATED BALLOON TRIAL "REFORM".
August 11, 2020 | News | Drug-eluting Balloons
The REFORM trial, utilises a Biolimus A9™ coated balloon, the latest development in Biosensors International balloon technology.
Blue Sail / Biosensors Intl. enters the Structural Heart business and welcomes NVT into the group
June 9,2020 | News | Corporate information
Biosensors International, part of Blue Sail Medical, announced today the completion of its acquisition of
NVT AG, Muri (Argau, Switzerland), which was previously communicated on September 20, 2019.
NEW ARC HBR DEFINITION
June 20,2019 | News | BioFreedom
For 7 years, we have been providing solutions to study and treat HBR patients.
Biosensors is proud to have contributed to increase the awareness of HBR patients who require an
Now, a new ARC HBR definition will continue to improve the care of these patients.
NEW: RISE™ NC NON-COMPLIANT BALLOON
July 8, 2019 | News | Rise
RISE™ NC provides you a new device to complement your tools during your procedure, delivering on the
performance you need. RISE NC is designed for deliverability and durability to allow for confident treatment
of your patients.